This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, E. L.
Right arrow Articles by Johnson, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, E. L.
Right arrow Articles by Johnson, D. R.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 101 No. 1 January 1998, pp. 86-88

Antistreptolysin O and Anti-Deoxyribonuclease B Titers: Normal Values for Children Ages 2 to 12 in the United States

Received Jun 4, 1997; accepted Jul 30, 1997.

Edward L. Kaplan*, Constance D. RothermelDagger , and Dwight R. Johnson*

From the * World Health Organization Collaborating Center for Reference and Research on Streptococci, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota; and Dagger  Roche Laboratories, Nutley, New Jersey.

Background.  Measurement of antibodies to the extracellular antigens produced by group A streptococci, antistreptolysin O (ASO) and anti-deoxyribonuclease B (anti-DNase B), is often necessary to confirm a clinical diagnosis of a previous group A streptococcal infection, especially in patients suspected of having a nonsuppurative sequel to this infection. Age is among several factors that may influence antibody levels in children. Thus, in contrast to adults, what is considered a normal titer for one age group (infants) is not appropriate for another (older children). Age-related "normal" values for ASO and anti-DNase B are provided in the package inserts of commercially available kits; however, there are no recent comprehensive data to validate such values.

Objective.  Using sera from 1131 children (from 23 states) ages 2 to 12 years, we determined age-specific geometric mean titers (GMT) and upper limits of normal (ULN) of ASO and anti-DNase B.

Methods.  ASO and anti-DNase B titers were measured by conventional laboratory methods.

Results.  Children 7 years of age comprised the largest proportion (14%) of the study population. Approximately two-thirds of the sera were collected during winter and early spring months. For both ASO and anti-DNase B, both GMT values and ULN increased with age. The GMTs for ASO and anti-DNase B for the entire group of subjects were 89 and 112, respectively. The ULN for the entire group for ASO and anti-DNase B were 240 and 640, respectively.

Conclusion.  The age-specific values for GMT and ULN for this group of children from 23 states were slightly higher than previously reported. These values are likely representative of the pediatric population in the United States and should be of clinical value to physicians, epidemiologists, and clinical laboratory personnel.

Key words: group A streptococci, antistreptolysin O (ASO), anti-deoxyribonuclease B (anti-DNase B), upper limits of normal, streptococcal antibody.




This article has been cited by other articles:


Home page
 J Child NeurolHome page
R. Rizzo, M. Gulisano, P. Pavone, F. Fogliani, and M. M. Robertson
Increased Antistreptococcal Antibody Titers and Anti--Basal Ganglia Antibodies in Patients With Tourette Syndrome: Controlled Cross-Sectional Study
J Child Neurol, September 1, 2006; 21(9): 747 - 753.
[PDF]

Home page
 PediatricsHome page
F. Luo, J. F. Leckman, L. Katsovich, D. Findley, H. Grantz, D. M. Tucker, P. J. Lombroso, R. A. King, and D. E. Bessen
Prospective Longitudinal Study of Children With Tic Disorders and/or Obsessive-Compulsive Disorder: Relationship of Symptom Exacerbations to Newly Acquired Streptococcal Infections
Pediatrics, June 1, 2004; 113(6): e578 - e585.
[Abstract] [Full Text]

Home page
 CVIHome page
E. M. Ayoub, B. Nelson, S. T. Shulman, D. J. Barrett, J. D. Campbell, G. Armstrong, J. Lovejoy, G. H. Angoff, and S. Rockenmacher
Group A Streptococcal Antibodies in Subjects with or without Rheumatic Fever in Areas with High or Low Incidences of Rheumatic Fever
Clin. Vaccine Immunol., September 1, 2003; 10(5): 886 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
L. H. Lee, E. Ayoub, and M. E. Pichichero
Fewer Symptoms Occur in Same-Serotype Recurrent Streptococcal Tonsillopharyngitis
Arch Otolaryngol Head Neck Surg, November 1, 2000; 126(11): 1359 - 1362.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
A. Eriksson, B. Eriksson, S. E. Holm, and M. Norgren
Streptococcal DNase B Is Immunologically Identical to Superantigen SpeF but Involves Separate Domains
Clin. Vaccine Immunol., January 1, 1999; 6(1): 133 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
M. P. DiFazio, J. Morales, and R. Davis
Acute Myoclonus Secondary to Group A {beta}-Hemolytic Streptococcus Infection: A PANDAS Variant
J Child Neurol, October 1, 1998; 13(10): 516 - 518.
[PDF]

Home page
 J Child NeurolHome page
M. A. Garvey, J. Giedd, and S. E. Swedo
Topical Review: PANDAS: The Search for Environmental Triggers of Pediatric Neuropsychiatric Disorders. Lessons from Rheumatic Fever
J Child Neurol, September 1, 1998; 13(9): 413 - 423.
[Abstract] [PDF]